Spyre Therapeutics Announces Grants of Inducement Awards

WALTHAM, Mass., March 06, 2026 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the “Company” or “Spyre”), a clinical-stage biotechnology company pioneering long-act...

Early report Major update Updated Mar 6, 2026, 9:05 PM UTC

Track this event Edit in app More event pages

What changed

Early report surfaced from GlobeNewswire Public Companies 4h ago.

First seen Mar 6, 2026, 9:05 PM UTC Latest source Mar 6, 2026, 9:05 PM UTC

Update 1 4h ago

Spyre Therapeutics Announces Grants of Inducement Awards

GlobeNewswire Public Companies •published Mar 6, 2026, 9:05 PM UTC •fetched Mar 6, 2026, 9:11 PM UTC